The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

34 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Metadynamics for Perspective Drug Design: Computationally Driven Synthesis of New Protein-Protein Interaction Inhibitors Targeting the EphA2 Receptor.EBI
University of Parma
Synthesis of Novel c(AmpRGD)-Sunitinib Dual Conjugates as Molecular Tools Targeting theaEBI
University of Parma
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors.EBI
University of Parma
¿(5)-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin system.EBI
University of Parma
Expanding the chemical space of human serine racemase inhibitors.EBI
University of Parma
2-Aminonicotinic acid 1-oxides are chemically stable inhibitors of quinolinic acid synthesis in the mammalian brain: a step toward new antiexcitotoxic agents.EBI
University of Parma
Amino acid conjugates of lithocholic acid as antagonists of the EphA2 receptor.EBI
University of Parma
Synthesis of (E)-8-(3-chlorostyryl)caffeine analogues leading to 9-deazaxanthine derivatives as dual A(2A) antagonists/MAO-B inhibitors.EBI
University of Parma
Design of O-acetylserine sulfhydrylase inhibitors by mimicking nature.EBI
University of Parma
Dibasic biphenyl H3 receptor antagonists: Steric tolerance for a lipophilic side chain.EBI
University of Parma
Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: steric effects of N-alkyl chain on rat plasma and liver stability.EBI
University of Parma
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity.EBI
University of Parma
Inhibition of NaV1.6 sodium channel currents by a novel series of 1,4-disubstituted-triazole derivatives obtained via copper-catalyzed click chemistry.EBI
University of Parma
Irreversible inhibition of epidermal growth factor receptor activity by 3-aminopropanamides.EBI
University of Parma
Discovery of subnanomolar arginine-glycine-aspartate-based alphaVbeta3/alphaVbeta5 integrin binders embedding 4-aminoproline residues.EBI
University of Parma
Grafting aminocyclopentane carboxylic acids onto the RGD tripeptide sequence generates low nanomolar alphaVbeta3/alphaVbeta5 integrin dual binders.EBI
University of Parma
Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 1. Models without explicit constrained water.EBI
University of Parma
Novel irreversible epidermal growth factor receptor inhibitors by chemical modulation of the cysteine-trap portion.EBI
University of Parma
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line.EBI
University of Parma
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma.EBI
University of Parma
A sulfonyl fluoride derivative inhibits EGFREBI
University of Parma
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties.EBI
University of Parma
Balancing reactivity and antitumor activity: heteroarylthioacetamide derivatives as potent and time-dependent inhibitors of EGFR.EBI
University of Parma
Benzisothiazolinone Derivatives as Potent Allosteric Monoacylglycerol Lipase Inhibitors That Functionally Mimic Sulfenylation of Regulatory Cysteines.EBI
University of Parma
Multitarget CFTR Modulators Endowed with Multiple Beneficial Side Effects for Cystic Fibrosis Patients: Toward a Simplified Therapeutic Approach †.EBI
University of Parma
Further insights into the SAR of α-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A.EBI
University of Parma
Long-lasting inhibition of EGFR autophosphorylation in A549 tumor cells by intracellular accumulation of non-covalent inhibitors.EBI
University of Parma
N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands.EBI
University of Parma
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid biphenyl scaffold.EBI
University of Parma
Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models.EBI
University of Parma
Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation.EBI
University of Parma
Targeting Eph/ephrin system in cancer therapy.EBI
University of Parma
Tetrahydroquinoline Ring as a Versatile Bioisostere of Tetralin for Melatonin Receptor Ligands.EBI
University of Parma
Atropisomerism and Conformational Equilibria: Impact on PI3Kδ Inhibition of 2-((6-Amino-9H-purin-9-yl)methyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one (IC87114) and Its Conformationally Restricted Analogs.EBI
University of Parma